12886_2019_1251_MOESM3_ESM.tif (1.53 MB)
MOESM3 of Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study
figure
posted on 2020-01-10, 04:53 authored by Giovanni Staurenghi, Justus Garweg, Bianca Gerendas, Wayne Macfadden, Boris Gekkiev, Philippe Margaron, Cornelia Dunger-Baldauf, Petr KolarAdditional file 3: Figure S1. BCVA and CSFT outcomes at Month 12 stratified by presence of extrafoveal CNV lesions at baseline (FAS).